69816-05-3 Usage
Description
METHYL 5-(CHLOROSULFONYL)-2-FUROATE is a chemical compound with the molecular formula C6H5ClO5S. It is a furoic acid derivative that contains a sulfone group and a chlorine atom. METHYL 5-(CHLOROSULFONYL)-2-FUROATE is known for its unique structure and reactivity, making it valuable for use in the creation of various organic compounds.
Uses
Used in Pharmaceutical Industry:
METHYL 5-(CHLOROSULFONYL)-2-FUROATE is used as an intermediate in the synthesis of pharmaceuticals. Its unique structure and reactivity make it valuable for the development of various organic compounds that can be used in the production of drugs.
Used in Agrochemical Industry:
METHYL 5-(CHLOROSULFONYL)-2-FUROATE is also used as an intermediate in the synthesis of agrochemicals. Its properties allow for the creation of compounds that can be used in the development of pesticides and other agricultural products.
Safety Precautions:
It is important to handle METHYL 5-(CHLOROSULFONYL)-2-FUROATE with caution, as it can be harmful if ingested or inhaled, and can cause skin and eye irritation. Proper handling and usage protocols must be followed to ensure safety and efficacy in its applications.
Check Digit Verification of cas no
The CAS Registry Mumber 69816-05-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,9,8,1 and 6 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 69816-05:
(7*6)+(6*9)+(5*8)+(4*1)+(3*6)+(2*0)+(1*5)=163
163 % 10 = 3
So 69816-05-3 is a valid CAS Registry Number.
InChI:InChI=1/C6H5ClO5S/c1-11-6(8)4-2-3-5(12-4)13(7,9)10/h2-3H,1H3
69816-05-3Relevant articles and documents
(R)-ARYLKYLAMINO DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
-
Page/Page column 15, (2008/06/13)
The present invention relates to selected (R)-arylalkylamino derivatives. These compounds show a surprising potent inhibitory effect on C5a induced human PMN chemotaxis. The compounds of the invention absolutely lack of CXCL8 inhibitory activity. Said com